Now What? - (Part 1)
A couple of weeks ago we hooked up to to an online webinar (‘The Results Are in – Now What?’) organised by the Treatment Action Group (TAG). It reviewed the results of two recent scientific trials, one looking at a new drug for MDR- and XDR-TB and the other evaluating a new regimen for treating MDR-TB. We have our own take on each (which we’ll discuss in Part 2), but in this first part we want to report on the webinar itself because it was extremely interesting in its import.